A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders

Clinical trial NCT04146285 · COMPLETED

Trial details

NCT number: NCT04146285
Sponsor: Bio-Thera Solutions
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neuromyelitis Optica Spectrum Disorders

Start date: 2020-09-01
Primary completion: 2023-03-13
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.